{"id":543336,"date":"2025-09-24T06:52:38","date_gmt":"2025-09-24T06:52:38","guid":{"rendered":"https:\/\/www.capgemini.com\/co-es\/?p=543336&#038;preview=true&#038;preview_id=543336"},"modified":"2025-09-24T06:53:09","modified_gmt":"2025-09-24T06:53:09","slug":"capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery","status":"publish","type":"post","link":"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery\/","title":{"rendered":"Capgemini and Insilico Medicine: Partnering to Accelerate AI-Powered Drug Discovery"},"content":{"rendered":"\n<header class=\"wp-block-cg-blocks-hero-blogs header-hero-blogs\"><div class=\"container\"><div class=\"hero-blogs\"><div class=\"hero-blogs-content-wrapper\"><div class=\"row\"><div class=\"col-12\"><div class=\"header-title\"><h1><strong>Capgemini and Insilico Medicine:<br>Partnering to Accelerate AI-Powered Drug Discovery<\/strong><\/h1><\/div><\/div><\/div><\/div><div class=\"hero-blogs-bottom\"><div class=\"header-author\"><div class=\"author-img\"><img decoding=\"async\" src=\"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2021\/08\/cg-logo-3.png?w=200&amp;quality=10\" alt=\"\" loading=\"lazy\"\/><\/div><div class=\"author-name-date\"><h5 class=\"author-name\">Capgemini<\/h5><h5 class=\"blog-date\">Sep 18, 2025<\/h5><\/div><\/div><div class=\"brand-image\"><\/div><\/div><\/div><\/div><\/header>\n\n\n\n<section class=\"wp-block-cg-blocks-intro-para section section--intro\"><div class=\"intro-para\"><div class=\"container\"><div class=\"row\"><div class=\"col-12 col-md-1\"><nav class=\"article-social\"><ul class=\"social-nav\"><li class=\"ip-order-fb\"><a href=\"https:\/\/www.facebook.com\/sharer\/sharer.php?u=https:\/\/www.capgemini.com\/co-es\/?p=543336\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"opens in a new window\"><i aria-hidden=\"true\" class=\"icon-fb\"><\/i><span class=\"sr-only\">Facebook<\/span><\/a><\/li><li class=\"ip-order-li\"><a href=\"https:\/\/www.linkedin.com\/sharing\/share-offsite\/?url=https:\/\/www.capgemini.com\/co-es\/?p=543336\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"opens in a new window\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><span class=\"sr-only\">Linkedin<\/span><\/a><\/li><\/ul><\/nav><\/div><div class=\"col-12 col-md-11 col-lg-10\"><h2 class=\"intro-para-title\">What began as a series of focused conversations has evolved into a partnership initiative, rooted in a shared ambition: to redefine the pace and precision of drug discovery through the power of AI, data, and science.<\/h2><\/div><\/div><\/div><\/div><\/section>\n\n\n\n<section class=\"wp-block-cg-blocks-group section section--article-content\"><div class=\"article-main-content\"><div class=\"container\"><div class=\"row\"><div class=\"col-12 col-md-11 col-lg-10 offset-md-1 offset-lg-1\"><div class=\"article-text article-quote-text\">\n<p>Capgemini and Insilico Medicine bring together complementary capabilities to address one of the life sciences industry\u2019s most urgent challenges\u2014improving R&amp;D productivity in a way that is measurable, scalable, and sustainable. This collaboration, driven by innovation and enabled by the Capgemini Ventures<sup>1<\/sup> team, reflects our shared commitment to shaping the future of drug discovery.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-a-shared-vision-for-innovation-in-life-sciences\"><strong>A Shared Vision for Innovation in Life Sciences<\/strong><\/h3>\n\n\n\n<p>Across the pharmaceutical landscape, there is a growing need to shorten development timelines, improve target identification, and reduce the risk of failure. Our collaboration is grounded in a joint recognition that advanced AI technologies\u2014when paired with scientific rigor and operational experience\u2014can help life sciences organizations respond to this new reality.<\/p>\n\n\n\n<p>Capgemini brings a deep understanding of the pharmaceutical industry, robust data management capabilities, and expertise in scaling AI solutions. Insilico Medicine, on the other hand, is a leading AI-driven drug discovery biotech company, with a validated AI-driven platform and proven track record of delivering preclinical candidates and clinical-stage assets at an accelerated pace. Together, we offer clients an end-to-end approach to reimagining the way their R&amp;D teams are structured and function.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-driving-lab-transformation-with-automation-and-ai\"><strong>Driving Lab Transformation with Automation and AI<\/strong><\/h3>\n\n\n\n<p>The future of lab work is intelligent, automated, and adaptive. Through this collaboration, we are helping organizations modernize their R&amp;D infrastructure with automated workflows &nbsp;and AI-powered solutions\u2014supporting lab digitization, real-time experiment tracking, and more consistent data generation.<\/p>\n\n\n\n<p>These advancements are key to enabling faster discovery cycles and more reproducible science.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-what-we-re-building-together\"><strong>What We\u2019re Building Together<\/strong><\/h3>\n\n\n\n<p>Our partnership focuses on projects where technology and science converge to disrupt how organizations do drug discovery. <\/p>\n\n\n\n<p>Examples include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Developing foundational AI models to support early experiment planning for specific therapeutic areas or discovery paths.<\/li>\n\n\n\n<li>Building data infrastructure for unique assays where no internal system exists\u2014replacing manual handoffs with structured, machine-readable datasets.<\/li>\n\n\n\n<li>Delivering drug discovery sprints that focus on defined targets or objectives in a compressed, agile timeframe.<\/li>\n\n\n\n<li>End-to-end digitized laboratory infrastructure where robots work together with agentic systems and humans in the loop.<\/li>\n<\/ul>\n\n\n\n<p>Each initiative is designed to reduce complexity, increase novelty, accelerate timelines, and to improve the probability of success of pre-clinical candidate molecules.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-addressing-key-client-challenges-together\"><strong>Addressing Key Client Challenges together<\/strong><\/h3>\n\n\n\n<p>We work closely with clients to solve complex problems across the early stages of drug discovery, including:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><em>Planning Experiments with Foundational Models<\/em><br>Clients need models that move beyond data interpretation\u2014toward active planning and insight generation for discovery programs.<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><em>Capturing Multi-Modal Data at High Quality<\/em><br>When assays are novel and internal tools are limited; clients often lack reliable data capture methods. We help build consistent, high-quality multi-modal datasets for AI training and scientific validation.<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><em>Executing Rapid Drug Discovery Sprints<\/em><br>Clients increasingly require focused, time-bound discovery sprints to test hypotheses quickly and efficiently. We provide the platforms, tools, and expertise to make this possible.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-strategic-advisory-on-digital-r-amp-d-organizational-changes-biomarkers-and-early-decision-making\"><strong>Strategic Advisory on digital R&amp;D organizational changes, Biomarkers and Early Decision-Making<\/strong><\/h3>\n\n\n\n<p>Successful implementation of AI-driven drug discovery at scale requires a fundamental shift in how R&amp;D organizations are set up across the people, process and technology elements. Capgemini\u2019s experience and scale in partnership with Insilico Medicine\u2019s AI\/ML expertise and experience with running AI-driven drug discovery programs allow us to uniquely advise on these critical elements that allow our client organizations to not just do point AI\/ML solutions but to grow and scale this capability to service their entire organization.<\/p>\n\n\n\n<p>In addition to technology implementation, while Insilico Medicine is experienced in biomarker identification, Capgemini plays a critical role in guiding clients on biomarker strategy. Our clients will benefit from identifying the right biomarkers early in the discovery process and designing data strategies that support clinical and commercial decision-making.<\/p>\n\n\n\n<p>This strategic advisory layer ensures that scientific innovation aligns with business goals\u2014an essential step in driving successful R&amp;D outcomes.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-a-foundation-for-future-growth\"><strong>A Foundation for Future Growth<\/strong><\/h3>\n\n\n\n<p>This collaboration reflects a broader shift in the industry: integrating AI, automation, and domain expertise to transform drug discovery. By combining Capgemini\u2019s strategic and operational capabilities with Insilico Medicine\u2019s innovation in AI, we\u2019re delivering value that extends across the R&amp;D lifecycle.<\/p>\n\n\n\n<p>Our partnership is built for long-term impact\u2014accelerating discovery, improving predictability, and helping our clients bring life-changing therapies to patients, faster.<\/p>\n\n\n\n<h5 class=\"wp-block-heading\" id=\"h-1-capgemini-ventures-nbsp-fosters-the-synergetic-blend-of-capgemini-s-extensive-experience-in-consulting-and-industry-services-with-cutting-edge-technology-solutions-of-the-most-innovative-startups-to-drive-innovation-and-deliver-value-to-our-clients\"><sup>1<\/sup><a href=\"https:\/\/www.capgemini.com\/about-us\/who-we-are\/innovation-ecosystem\/capgemini-ventures\/\"><strong>Capgemini Ventures<\/strong> <\/a><strong>&nbsp;fosters the synergetic blend of Capgemini\u2019s extensive experience in consulting and industry services with cutting-edge technology solutions of the most innovative startups to drive innovation and deliver value to our clients.<\/strong><\/h5>\n<\/div><\/div><\/div><\/div><\/div><\/section>\n\n\n\n<section class=\"section section--expert-slider wrapper-people-slider wp-block-cg-blocks-wrapper-people-slider\"><div class=\"container\"><div class=\"content-title\"><h2 data-maxlength=\"34\" class=\"people-heading-title\">Authors<\/h2><\/div><\/div><div class=\"slider slider-boxed\"><div class=\"container\"><div class=\"slider-window\"><div class=\"slider-list\">\t\t<div class=\"slide\">\n\t\t\t<div class=\"box\">\n\t\t\t\t<div class=\"row\">\n\t\t\t\t\t<div class=\"col-md-6 col-lg-4 box-img-wrapper\">\n\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/09\/Dr-Parvin-Moyassari_Image.jpg\" alt=\"Dr. Parvin Moyassari\"\/>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<div class=\"col-md-6 col-lg-8 box-inner\">\n\t\t\t\t\t\t<div class=\"row title-social-media-header\">\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 mbl-social-icon\">\n\t\t\t\t\t\t\t\t<ul class=\"social-nav\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li><a aria-label=\"Linkedin\" target=\"_blank\" title=\"abrir en una nueva ventana\" href=\"https:\/\/www.linkedin.com\/in\/dr-parvin-moyassari\/\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><\/a><\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 box-container\">\n\t\t\t\t\t\t\t\t<div class=\"box-title\">\n\t\t\t\t\t\t\t\t\t<h3 class=\"people-profile-title\">Dr. Parvin Moyassari<\/h3>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span>Global Head of Life Sciences, Insight &amp; Data \u2013 Capgemini<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 social-box-container dkt-social-icon\">\n\t\t\t\t\t\t\t\t<ul class=\"social-nav\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li><a aria-label=\"Linkedin\" target=\"_blank\" title=\"abrir en una nueva ventana\" href=\"https:\/\/www.linkedin.com\/in\/dr-parvin-moyassari\/\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><\/a><\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"people-info\">Parvin leads Capgemini\u2019s global Life Sciences at Insight &#038; Data practice, where she brings together scientific depth and digital innovation to transform life sciences industry. With over 18 years of experience in AI, data analytics and digital transformation, she drives strategic initiatives that unlock the power of data and AI to improve health outcomes, streamline operations, and enable smarter decision-making. Her work is at the forefront of shaping the future of pharmaceutical intelligence, bridging cutting-edge technology with real-world impact.<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div><\/div><\/div><div class=\"slider-nav\"><button class=\"slider-prev inactive\" aria-label=\"Slider-previous\" tabindex=\"-1\"><\/button><ul class=\"slider-paginator\"><\/ul><button class=\"slider-next\" aria-label=\"Slider-next\"><\/button><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"<p>Capgemini and Insilico Medicine: Partnering to Accelerate AI-Powered Drug Discovery<\/p>\n","protected":false},"author":699,"featured_media":543337,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"cg_dt_proposed_to":[],"cg_seo_hreflang_relations":"[]","cg_seo_canonical_relation":"","cg_seo_hreflang_x_default_relation":"","cg_dt_approved_content":true,"cg_dt_mandatory_content":false,"cg_dt_notes":"","cg_dg_source_changed":false,"cg_dt_link_disabled":false,"_yoast_wpseo_primary_brand":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","featured_focal_points":""},"categories":[1],"tags":[],"brand":[],"service":[100,105],"industry":[119],"partners":[],"blog-topic":[47,49,54],"content-group":[],"class_list":["post-543336","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","service-customer-experience","service-intelligent-industry","industry-life-sciences","blog-topic-customer-experience","blog-topic-data-and-ai","blog-topic-intelligent-industry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.8 (Yoast SEO v22.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Capgemini and Insilico Medicine: Partnering to Accelerate AI-Powered Drug Discovery - Capgemini Colombia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Capgemini and Insilico Medicine: Partnering to Accelerate AI-Powered Drug Discovery\" \/>\n<meta property=\"og:description\" content=\"Capgemini and Insilico Medicine: Partnering to Accelerate AI-Powered Drug Discovery\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery\/\" \/>\n<meta property=\"og:site_name\" content=\"Capgemini Colombia\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-24T06:52:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-24T06:53:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/10\/New-Web-preview-global.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Capgemini\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"elishavalekar\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery\/\",\"url\":\"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery\/\",\"name\":\"Capgemini and Insilico Medicine: Partnering to Accelerate AI-Powered Drug Discovery - Capgemini Colombia\",\"isPartOf\":{\"@id\":\"https:\/\/www.capgemini.com\/co-es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/09\/LS-project-2880-x1880-px-dotcom-Banner.jpg\",\"datePublished\":\"2025-09-24T06:52:38+00:00\",\"dateModified\":\"2025-09-24T06:53:09+00:00\",\"author\":{\"@id\":\"https:\/\/www.capgemini.com\/co-es\/#\/schema\/person\/d5a00e336d198ead20a92fc1ca50cc2b\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery\/#breadcrumb\"},\"inLanguage\":\"es-MX\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es-MX\",\"@id\":\"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery\/#primaryimage\",\"url\":\"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/09\/LS-project-2880-x1880-px-dotcom-Banner.jpg\",\"contentUrl\":\"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/09\/LS-project-2880-x1880-px-dotcom-Banner.jpg\",\"width\":2880,\"height\":1880},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.capgemini.com\/co-es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Capgemini and Insilico Medicine: Partnering to Accelerate AI-Powered Drug Discovery\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.capgemini.com\/co-es\/#website\",\"url\":\"https:\/\/www.capgemini.com\/co-es\/\",\"name\":\"Capgemini Colombia\",\"description\":\"Capgemini\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.capgemini.com\/co-es\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es-MX\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.capgemini.com\/co-es\/#\/schema\/person\/d5a00e336d198ead20a92fc1ca50cc2b\",\"name\":\"elishavalekar\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es-MX\",\"@id\":\"https:\/\/www.capgemini.com\/co-es\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ddbecdbccdad1dd8b32a065814a45d631db326b06e3c1682c69cf1356da99377?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ddbecdbccdad1dd8b32a065814a45d631db326b06e3c1682c69cf1356da99377?s=96&d=mm&r=g\",\"caption\":\"elishavalekar\"},\"url\":\"https:\/\/www.capgemini.com\/co-es\/author\/elishavalekar\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Capgemini and Insilico Medicine: Partnering to Accelerate AI-Powered Drug Discovery - Capgemini Colombia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery\/","og_locale":"es_MX","og_type":"article","og_title":"Capgemini and Insilico Medicine: Partnering to Accelerate AI-Powered Drug Discovery","og_description":"Capgemini and Insilico Medicine: Partnering to Accelerate AI-Powered Drug Discovery","og_url":"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery\/","og_site_name":"Capgemini Colombia","article_published_time":"2025-09-24T06:52:38+00:00","article_modified_time":"2025-09-24T06:53:09+00:00","og_image":[{"width":1200,"height":627,"url":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/10\/New-Web-preview-global.jpg","type":"image\/jpeg"}],"author":"Capgemini","twitter_card":"summary_large_image","twitter_misc":{"Written by":"elishavalekar","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery\/","url":"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery\/","name":"Capgemini and Insilico Medicine: Partnering to Accelerate AI-Powered Drug Discovery - Capgemini Colombia","isPartOf":{"@id":"https:\/\/www.capgemini.com\/co-es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery\/#primaryimage"},"image":{"@id":"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery\/#primaryimage"},"thumbnailUrl":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/09\/LS-project-2880-x1880-px-dotcom-Banner.jpg","datePublished":"2025-09-24T06:52:38+00:00","dateModified":"2025-09-24T06:53:09+00:00","author":{"@id":"https:\/\/www.capgemini.com\/co-es\/#\/schema\/person\/d5a00e336d198ead20a92fc1ca50cc2b"},"breadcrumb":{"@id":"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery\/#breadcrumb"},"inLanguage":"es-MX","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery\/"]}]},{"@type":"ImageObject","inLanguage":"es-MX","@id":"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery\/#primaryimage","url":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/09\/LS-project-2880-x1880-px-dotcom-Banner.jpg","contentUrl":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/09\/LS-project-2880-x1880-px-dotcom-Banner.jpg","width":2880,"height":1880},{"@type":"BreadcrumbList","@id":"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.capgemini.com\/co-es\/"},{"@type":"ListItem","position":2,"name":"Capgemini and Insilico Medicine: Partnering to Accelerate AI-Powered Drug Discovery"}]},{"@type":"WebSite","@id":"https:\/\/www.capgemini.com\/co-es\/#website","url":"https:\/\/www.capgemini.com\/co-es\/","name":"Capgemini Colombia","description":"Capgemini","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.capgemini.com\/co-es\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es-MX"},{"@type":"Person","@id":"https:\/\/www.capgemini.com\/co-es\/#\/schema\/person\/d5a00e336d198ead20a92fc1ca50cc2b","name":"elishavalekar","image":{"@type":"ImageObject","inLanguage":"es-MX","@id":"https:\/\/www.capgemini.com\/co-es\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ddbecdbccdad1dd8b32a065814a45d631db326b06e3c1682c69cf1356da99377?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ddbecdbccdad1dd8b32a065814a45d631db326b06e3c1682c69cf1356da99377?s=96&d=mm&r=g","caption":"elishavalekar"},"url":"https:\/\/www.capgemini.com\/co-es\/author\/elishavalekar\/"}]}},"blog_topic_info":[{"id":47,"name":"Customer experience"},{"id":49,"name":"Data and AI"},{"id":54,"name":"Intelligent industry"}],"taxonomy_info":{"category":[{"id":1,"name":"Uncategorized","slug":"uncategorized"}],"service":[{"id":100,"name":"Customer experience","slug":"customer-experience"},{"id":105,"name":"Intelligent Industry","slug":"intelligent-industry"}],"industry":[{"id":119,"name":"Life sciences","slug":"life-sciences"}],"blog-topic":[{"id":47,"name":"Customer experience","slug":"customer-experience"},{"id":49,"name":"Data and AI","slug":"data-and-ai"},{"id":54,"name":"Intelligent industry","slug":"intelligent-industry"}],"following_users":[{"id":460,"name":"elishavalekar","slug":"elishavalekar"},{"id":224,"name":"vikramjanugade","slug":"vikramjanugade"}]},"parsely":{"version":"1.1.0","canonical_url":"https:\/\/capgemini.com\/co-es\/insights\/expert-perspectives\/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery\/","smart_links":{"inbound":0,"outbound":0},"traffic_boost_suggestions_count":0,"meta":{"@context":"https:\/\/schema.org","@type":"NewsArticle","headline":"Capgemini and Insilico Medicine: Partnering to Accelerate AI-Powered Drug Discovery","url":"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery\/","mainEntityOfPage":{"@type":"WebPage","@id":"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery\/"},"thumbnailUrl":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/09\/LS-project-2880-x1880-px-dotcom-Banner.jpg?w=150&h=150&crop=1","image":{"@type":"ImageObject","url":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/09\/LS-project-2880-x1880-px-dotcom-Banner.jpg"},"articleSection":"Uncategorized","author":[],"creator":[],"publisher":{"@type":"Organization","name":"Capgemini Colombia","logo":""},"keywords":[],"dateCreated":"2025-09-24T06:52:38Z","datePublished":"2025-09-24T06:52:38Z","dateModified":"2025-09-24T06:53:09Z"},"rendered":"<meta name=\"parsely-title\" content=\"Capgemini and Insilico Medicine: Partnering to Accelerate AI-Powered Drug Discovery\" \/>\n<meta name=\"parsely-link\" content=\"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery\/\" \/>\n<meta name=\"parsely-type\" content=\"post\" \/>\n<meta name=\"parsely-image-url\" content=\"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/09\/LS-project-2880-x1880-px-dotcom-Banner.jpg?w=150&amp;h=150&amp;crop=1\" \/>\n<meta name=\"parsely-pub-date\" content=\"2025-09-24T06:52:38Z\" \/>\n<meta name=\"parsely-section\" content=\"Uncategorized\" \/>","tracker_url":"https:\/\/cdn.parsely.com\/keys\/capgemini.com\/p.js"},"jetpack_featured_media_url":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/09\/LS-project-2880-x1880-px-dotcom-Banner.jpg","archive_status":false,"featured_image_src":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/09\/LS-project-2880-x1880-px-dotcom-Banner.jpg","featured_image_alt":"","jetpack_sharing_enabled":true,"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"Capgemini Colombia","distributor_original_site_url":"https:\/\/www.capgemini.com\/co-es","push-errors":false,"featured_image_url":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/09\/LS-project-2880-x1880-px-dotcom-Banner.jpg","author_title":"Capgemini","author_thumbnail_url":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2021\/08\/cg-logo-3.png?w=330","author_thumbnail_alt":"","_links":{"self":[{"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/posts\/543336","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/users\/699"}],"replies":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/comments?post=543336"}],"version-history":[{"count":1,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/posts\/543336\/revisions"}],"predecessor-version":[{"id":543340,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/posts\/543336\/revisions\/543340"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/media\/543337"}],"wp:attachment":[{"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/media?parent=543336"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/categories?post=543336"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/tags?post=543336"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/brand?post=543336"},{"taxonomy":"service","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/service?post=543336"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/industry?post=543336"},{"taxonomy":"partners","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/partners?post=543336"},{"taxonomy":"blog-topic","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/blog-topic?post=543336"},{"taxonomy":"content-group","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/content-group?post=543336"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}